+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Fine Chemicals Market Research Report: By Drug Type, Product, Application - Global Industry Analysis and Growth Forecast to 2030

  • ID: 5128877
  • Report
  • April 2020
  • Region: Global
  • 206 pages
  • Prescient & Strategic Intelligence Private Limited
1 of 3

FEATURED COMPANIES

  • Albemarle Corporation
  • BASF SE
  • Borregaard ASA
  • Clariant AG
  • DuPont de Nemours Inc.
  • Eastman Chemical Company
  • MORE
The global pharmaceutical fine chemicals market generated a revenue of $100.3 billion in 2019, and it is predicted to grow at a 6.2% CAGR during the forecast period (2020–2030). The major driving factors of the market are the surging geriatric population, and rapid expansion of the pharmaceutical industry in the Asia-Pacific (APAC) region. In terms of drug type, the pharmaceutical fine chemicals market is bifurcated into non-proprietary and proprietary, between which, the proprietary drug bifurcation accounted for the larger revenue share of the market.

This is because of the fact that the production of these drugs requires high capital investment, compliance to stringent regulations, strong research & development efforts, and adequate quality control measures. On the basis of product, the pharmaceutical fine chemicals market is categorized into active ingredients, basic building blocks, and advanced intermediaries. Out of these, the active ingredients category is predicted to advance at the fastest pace during the forecast period. These are the most important component of the drug, since they accomplish the purpose of medication, owing to which, their demand is predicted to increase.

The surging aging population is one of the major driving factors of the pharmaceuticals fine chemicals market. According to the latest World Population Ageing report by the United Nations Department of Economic and Social Affairs, the number of people aged 65 and above is expected to increase to 1.5 billion by 2050. Because of their physical weakness and immunocompromised nature, aged people fall sick more often than adults and children, which is why, the need for medical drugs is higher for them. This is further creating the need for chemicals to produce drugs.

The growing awareness in Africa is expected to open up wide opportunities for players operating in the pharmaceuticals fine chemical market. The governments of various countries in the region, such as Nigeria and Kenya, are encouraging the local production of medical drugs, which is primarily aimed at improving the accessibility of these products. Countries in the region are further focusing on enhancing the public health and aiming to have a larger and healthier workforce for the benefit of national economy. These aspects are projected to result in the growth of the market.

When application is taken into consideration, the pharmaceutical fine chemicals market is divided into musculoskeletal, cardiovascular, gastrointestinal, neurological, respiratory, and oncological. The largest revenue share of the market during the forecast period is predicted to be held by the cardiovascular division. This is due to the growing prevalence of cardiovascular diseases, such as hypertension, stroke, coronary artery disease, and arrhythmias. This is leading to the increasing demand for heart medication, which, in turn, is driving the demand for pharmaceutical fine chemicals.

Geographically, North America accounted for the major revenue share of the pharmaceutical fine chemicals market during the historical period (2014–2019). This is because of the fact that the region has the largest pharmaceutical industry in the region and further accounts for increased high healthcare expenditure. In addition to this, various drug manufacturers in the region are pursuing research & development activities for coming up with medication for the rising number of presently-untreatable diseases.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Albemarle Corporation
  • BASF SE
  • Borregaard ASA
  • Clariant AG
  • DuPont de Nemours Inc.
  • Eastman Chemical Company
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Drug Type
1.3.2 Market Segmentation by Product
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by Geography
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Volume
1.3.6.2 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Drug Type
4.1.1.1 Proprietary
4.1.1.2 Non-proprietary
4.1.2 By Product
4.1.2.1 Basic building blocks
4.1.2.2 Advanced intermediates
4.1.2.3 Active ingredients
4.1.3 By Application
4.1.3.1 Cardiovascular
4.1.3.2 Neurological
4.1.3.3 Oncological
4.1.3.4 Respiratory
4.1.3.5 Gastrointestinal
4.1.3.6 Musculoskeletal
4.1.3.7 Others
4.2 Value Chain Analysis
4.3 Impact of Covid-19 on Global Pharmaceutical Fine Chemicals Market
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Growing geriatric population
4.4.1.2 Rapid growth of pharmaceutical sector in APAC
4.4.1.3 Impact analysis of drivers on market forecast
4.4.2 Restraints
4.4.2.1 Impact on the environment
4.4.2.2 Impact analysis of restraints on market forecast
4.4.3 Opportunities
4.4.3.1 Growing awareness in the African region
4.5 Porter’s Five Forces Analysis
4.5.1 Bargaining Power of Buyers
4.5.2 Bargaining Power of Suppliers
4.5.3 Intensity of Competitive Rivalry
4.5.4 Threat of New Entrants
4.5.5 Threat of Substitutes

Chapter 5. Regulatory Framework
5.1 U.S.
5.2 Canada
5.3 U.K.
5.4 China
5.5 Japan
5.6 South Korea
5.7 Australia

Chapter 6. Global Market Size and Forecast
6.1 By Drug Type
6.2 By Product
6.3 By Application
6.4 By Region

Chapter 7. North America Market Size and Forecast
7.1 By Drug Type
7.2 By Product
7.3 By Application
7.4 By Country

Chapter 8. Europe Market Size and Forecast
8.1 By Drug Type
8.2 By Product
8.3 By Application
8.4 By Country

Chapter 9. APAC Market Size and Forecast
9.1 By Drug Type
9.2 By Product
9.3 By Application
9.4 By Country

Chapter 10. LATAM Market Size and Forecast
10.1 By Drug Type
10.2 By Product
10.3 By Application
10.4 By Country

Chapter 11. MEA Market Size and Forecast
11.1 By Drug Type
11.2 By Product
11.3 By Application
11.4 By Country

Chapter 12. Competitive Landscape
12.1 Market Share Analysis of Key Players
12.2 Strategic Developments of Key Players
12.2.1 Mergers and Acquisitions
12.2.2 Partnerships, Collaborations, and Joint Ventures
12.2.3 Product Launches
12.2.4 Facility Expansions
12.2.5 Other Developments
12.3 List of Players and Their Offerings

Chapter 13. Company Profiles
13.1 BASF SE
13.1.1 Business Overview
13.1.2 Product and Service Offerings
13.1.3 Key Financial Summary
13.2 Eastman Chemical Company
13.2.1 Business Overview
13.2.2 Product and Service Offerings
13.2.3 Key Financial Summary
13.3 WeylChem International GmbH
13.3.1 Business Overview
13.3.2 Product and Service Offerings
13.4 Borregaard ASA
13.4.1 Business Overview
13.4.2 Product and Service Offerings
13.4.3 Key Financial Summary
13.5 Lonza Group Ltd.
13.5.1 Business Overview
13.5.2 Product and Service Offerings
13.5.3 Key Financial Summary
13.6 Clariant AG
13.6.1 Business Overview
13.6.2 Product and Service Offerings
13.6.3 Key Financial Summary
13.7 Solvay S.A.
13.7.1 Business Overview
13.7.2 Product and Service Offerings
13.7.3 Key Financial Summary
13.8 Evonik Industries AG
13.8.1 Business Overview
13.8.2 Product and Service Offerings
13.8.3 Key Financial Summary
13.9 Albemarle Corporation
13.9.1 Business Overview
13.9.2 Product and Service Offerings
13.9.3 Key Financial Summary
13.10 DuPont de Nemours Inc.
13.10.1 Business Overview
13.10.2 Product and Service Offerings
13.10.3 Key Financial Summary
13.11 Koninklijke DSM N.V.
13.11.1 Business Overview
13.11.2 Product and Service Offerings
13.11.3 Key Financial Summary
13.12 Merck KGaA
13.12.1 Business Overview
13.12.2 Product and Service Offerings
13.12.3 Key Financial Summary

Chapter 14. Appendix
14.1 Abbreviations
14.2 Sources and References
14.3 Related Reports

List of Tables

TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2019)
TABLE 5 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2020-2025)
TABLE 6 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2026-2030)
TABLE 7 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2014-2019)
TABLE 8 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2020-2025)
TABLE 9 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2026-2030)
TABLE 10 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2019)
TABLE 11 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2020-2025)
TABLE 12 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2026-2030)
TABLE 13 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2014-2019)
TABLE 14 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2020-2025)
TABLE 15 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2026-2030)
TABLE 16 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2019)
TABLE 17 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2020-2025)
TABLE 18 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2026-2030)
TABLE 19GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2014-2019)
TABLE 20 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2020-2025)
TABLE 21 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2026-2030)
TABLE 22 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, KILOTONS (2014-2019)
TABLE 23 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, KILOTONS (2020-2025)
TABLE 24 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, KILOTONS (2026-2030)
TABLE 25 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, $B (2014-2019)
TABLE 26 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, $B (2020-2025)
TABLE 27 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, $B (2026-2030)
TABLE 28 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2019)
TABLE 29 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2020-2025)
TABLE 30 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2026-2030)
TABLE 31 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2014-2019)
TABLE 32 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2020-2025)
TABLE 33 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2026-2030)
TABLE 34 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2019)
TABLE 35 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2020-2025)
TABLE 36 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2026-2030)
TABLE 37 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2014-2019)
TABLE 38 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2020-2025)
TABLE 39 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2026-2030)
TABLE 40 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2019)
TABLE 41 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2020-2025)
TABLE 42 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2026-2030)
TABLE 43 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2014-2019)
TABLE 44 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2020-2025)
TABLE 45 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2026-2030)
TABLE 46 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2019)
TABLE 47 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2020-2025)
TABLE 48 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2026-2030)
TABLE 49 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2014-2019)
TABLE 50 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2020-2025)
TABLE 51 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2026-2030)
TABLE 52 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2019)
TABLE 53 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2020-2025)
TABLE 54 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2026-2030)
TABLE 55 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2014-2019)
TABLE 56 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2020-2025)
TABLE 57 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2026-2030)
TABLE 58 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2019)
TABLE 59 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2020-2025)
TABLE 60 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2026-2030)
TABLE 61 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2014-2019)
TABLE 62 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2020-2025)
TABLE 63 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2026-2030)
TABLE 64 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2019)
TABLE 65 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2020-2025)
TABLE 66 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2026-2030)
TABLE 67 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2014-2019)
TABLE 68 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2020-2025)
TABLE 69 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2026-2030)
TABLE 70 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2019)
TABLE 71 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2020-2025)
TABLE 72 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2026-2030)
TABLE 73 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2014-2019)
TABLE 74 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2020-2025)
TABLE 75 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2026-2030)
TABLE 76 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2019)
TABLE 77 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2020-2025)
TABLE 78 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2026-2030)
TABLE 79 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2014-2019)
TABLE 80 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2020-2025)
TABLE 81 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2026-2030)
TABLE 82 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2019)
TABLE 83 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2020-2025)
TABLE 84 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2026-2030)
TABLE 85 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2014-2019)
TABLE 86 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2020-2025)
TABLE 87 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2026-2030)
TABLE 88 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2019)
TABLE 89 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2020-2025)
TABLE 90 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2026-2030)
TABLE 91 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2014-2019)
TABLE 92 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2020-2025)
TABLE 93 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2026-2030)
TABLE 94 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2019)
TABLE 95 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2020-2025)
TABLE 96 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2026-2030)
TABLE 97 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2014-2019)
TABLE 98 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2020-2025)
TABLE 99 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2026-2030)
TABLE 100 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2019)
TABLE 101 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2020-2025)
TABLE 102 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2026-2030)
TABLE 103 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2014-2019)
TABLE 104 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2020-2025)
TABLE 105 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2026-2030)
TABLE 106 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2019)
TABLE 107 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2020-2025)
TABLE 108 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2026-2030)
TABLE 109 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2014-2019)
TABLE 110 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2020-2025)
TABLE 111 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2026-2030)
TABLE 112 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2019)
TABLE 113 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2020-2025)
TABLE 114 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2026-2030)
TABLE 115 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2014-2019)
TABLE 116 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2020-2025)
TABLE 117 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2026-2030)
TABLE 118 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2019)
TABLE 119 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2020-2025)
TABLE 120 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2026-2030)
TABLE 121 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2014-2019)
TABLE 122 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2020-2025)
TABLE 123 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2026-2030)
TABLE 124 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2019)
TABLE 125 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2020-2025)
TABLE 126 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2026-2030)
TABLE 127 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2014-2019)
TABLE 128 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2020-2025)
TABLE 129 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, $B (2026-2030)
TABLE 130 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2019)
TABLE 131 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2020-2025)
TABLE 132 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2026-2030)
TABLE 133 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2014-2019)
TABLE 134 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2020-2025)
TABLE 135 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, $B (2026-2030)
TABLE 136 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2019)
TABLE 137 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2020-2025)
TABLE 138 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2026-2030)
TABLE 139 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2014-2019)
TABLE 140 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2020-2025)
TABLE 141 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, $B (2026-2030)
TABLE 142 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2019)
TABLE 143 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2020-2025)
TABLE 144 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2026-2030)
TABLE 145 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2014-2019)
TABLE 146 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2020-2025)
TABLE 147 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, $B (2026-2030)
TABLE 148 LIST OF KEY PLAYERS AND THEIR OFFERINGS
TABLE 149 BASF SE - AT A GLANCE
TABLE 150 BASF SE - KEY FINANCIAL SUMMARY
TABLE 151 EASTMAN CHEMICAL COMPANY - AT A GLANCE
TABLE 152 EASTMAN CHEMICAL COMPANY - KEY FINANCIAL SUMMARY
TABLE 153 WEYLCHEM INTERNATIONAL GMBH - AT A GLANCE
TABLE 154 BORREGAARD ASA - AT A GLANCE
TABLE 155 BORREGAARD ASA - KEY FINANCIAL SUMMARY
TABLE 156 LONZA GROUP LTD. - AT A GLANCE
TABLE 157 LONZA GROUP LTD. - KEY FINANCIAL SUMMARY
TABLE 158 CLARIANT AG - AT A GLANCE
TABLE 159 CLARIANT AG - KEY FINANCIAL SUMMARY
TABLE 160 SOLVAY S.A. - AT A GLANCE
TABLE 161 SOLVAY S.A. - KEY FINANCIAL SUMMARY
TABLE 162 EVONIK INDUSTRIES AG - AT A GLANCE
TABLE 163 EVONIK INDUSTRIES AG - KEY FINANCIAL SUMMARY
TABLE 164 ALBEMARLE CORPORATION - AT A GLANCE
TABLE 165 ALBEMARLE CORPORATION - KEY FINANCIAL SUMMARY
TABLE 166 DUPONT DE NEMOURS INC. - AT A GLANCE
TABLE 167 DUPONT DE NEMOURS INC. - KEY FINANCIAL SUMMARY
TABLE 168 KONINKLIJKE DSM N.V. - AT A GLANCE
TABLE 169 KONINKLIJKE DSM N.V. - KEY FINANCIAL SUMMARY
TABLE 170 MERCK KGAA - AT A GLANCE
TABLE 171 MERCK KGAA - KEY FINANCIAL SUMMARY

List of Figures

FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET SUMMARY
FIG 8 VALUE CHAIN ANALYSIS
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF COMPETITIVE RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL PHARMACETICAL FINE CHEMICALS MARKET SNAPSHOT
FIG 15 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2030)
FIG 16 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2030)
FIG 17 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2030)
FIG 18 WORLDWIDE MAJOR MARKETS FOR PHARMACEUTICAL FINE CHEMICALS
FIG 19 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION, KILOTONS (2014-2030)
FIG 20 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET SNAPSHOT
FIG 21 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2030)
FIG 22 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2030)
FIG 23 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2030)
FIG 24 NORTH AMERICA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2030)
FIG 25 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET SNAPSHOT
FIG 26 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2030)
FIG 27 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2030)
FIG 28 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2030)
FIG 29 EUROPE PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2030)
FIG 30 APAC PHARMACEUTICAL FINE CHEMICALS MARKET SNAPSHOT
FIG 31 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2030)
FIG 32 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2030)
FIG 33 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2030)
FIG 34 APAC PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2030)
FIG 35 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET SNAPSHOT
FIG 36 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2030)
FIG 37 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2030)
FIG 38 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2030)
FIG 39 LATAM PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2030)
FIG 40 MEA PHARMACEUTICAL FINE CHEMICALS MARKET SNAPSHOT
FIG 41 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY DRUG TYPE, KILOTONS (2014-2030)
FIG 42 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT, KILOTONS (2014-2030)
FIG 43 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION, KILOTONS (2014-2030)
FIG 44 MEA PHARMACEUTICAL FINE CHEMICALS MARKET, BY COUNTRY, KILOTONS (2014-2030)
FIG 45 GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET SHARE OF KEY PLAYERS (2019)
FIG 46 BASF SE - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 47 EASTMAN CHEMICAL COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 48 BORREGAARD ASA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 49 LONZA GROUP LTD. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 50 CLARIANT AG - REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2019)
FIG 51 SOLVAY S.A. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 52 EVONIK INDUSTRIES AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 53 ALBEMARLE CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 54 DUPONT DE NEMOURS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 55 KONINKLIJKE DSM N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 56 MERCK KGAA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
3 of 3
  • BASF SE
  • Eastman Chemical Company
  • WeylChem International GmbH
  • Borregaard ASA
  • Lonza Group Ltd.
  • Clariant AG
  • Solvay S.A.
  • Evonik Industries AG
  • Albemarle Corporation
  • DuPont de Nemours Inc.
  • Koninklijke DSM N.V.
  • Merck KGaA
Note: Product cover images may vary from those shown
Adroll
adroll